About aol
Manuscript Submission
AME Editing Service
Reprint & Permission
Advertising
Contact us
-
General editorial enquiries:
Email: aol@amegroups.com -
Copyright related contact:
Email: permissions@amegroups.com -
Commercial Sales contact (Reprints, advertising, etc.):
Email: sales@amegroups.com
Review Article
Annals of Lymphoma
2024;
8:
6
(30 October 2024)
Case Report
Annals of Lymphoma
2024;
8:
5
(30 July 2024)
Case Report
Annals of Lymphoma
2024;
8:
4
(30 June 2024)
Original Article
Annals of Lymphoma
2024;
8:
3
(30 May 2024)
Case Report
Annals of Lymphoma
2024;
8:
2
(30 May 2024)
Review Article
Annals of Lymphoma
2024;
8:
1
(30 May 2024)
Case Report
Annals of Lymphoma
2023;
7:
2
(30 March 2023)
Original Article
Annals of Lymphoma
2023;
7:
1
(28 February 2023)
Review Article
Annals of Lymphoma
2022;
6:
13
(30 December 2022)
Review Article
Annals of Lymphoma
2022;
6:
12
(30 December 2022)
Review Article
Annals of Lymphoma
2022;
6:
11
(30 September 2022)
Review Article
Annals of Lymphoma
2022;
6:
10
(30 September 2022)
Review Article
Annals of Lymphoma
2022;
6:
9
(30 September 2022)
Review Article
Annals of Lymphoma
2022;
6:
8
(30 September 2022)
Review Article
Annals of Lymphoma
2022;
6:
6
(30 June 2022)
Review Article
Annals of Lymphoma
2022;
6:
5
(30 June 2022)
Editorial
Annals of Lymphoma
2022;
6:
4
(30 June 2022)
Case Report
Annals of Lymphoma
2022;
6:
3
(30 March 2022)
Case Report
Annals of Lymphoma
2022;
6:
2
(30 March 2022)
Currently no content available!
Review Article
Review Article
Review Article
Review Article
Review Article
Review Article
Review Article
Review Article
Review Article
Review Article
Review Article
Review Article
Review Article
Review Article
Review Article
Review Article
Review Article
Review Article
Review Article
Review Article